export default function OncologyIntro() {
  return (
    <section className="mx-auto px-10 pt-12">
      <h1 className="text-4xl font-bold text-gray-700 text-left pb-2 mb-4">Oncology</h1>
      <h2 className="text-2xl font-semibold text-gray-700 mb-4">Turning Complexity into Clarity</h2>
      <p className="text-gray-600 leading-relaxed text-base mb-4 text-justify">
        Cancer is not a single disease—it's a highly complex and dynamic group of disorders, 
        often driven by a multitude of genomic alterations. Despite advancements in treatment, 
        many patients still face uncertainty due to incomplete or delayed molecular diagnoses.
      </p>
      <p className="text-gray-600 leading-relaxed text-base mb-4 text-justify">
        At Operify Health, we recognize that behind every tumor is a unique genetic story waiting 
        to be told. Our precision oncology solutions utilize high-throughput Next Generation 
        Sequencing (NGS) to analyze both somatic and germline mutations—providing clinicians 
        with actionable insights that inform targeted therapies, immunotherapy decisions, and 
        hereditary cancer risk assessments.
      </p>
      <p className="text-gray-600 leading-relaxed text-base mb-4 text-justify">
        This genomic-driven approach is especially critical in advanced and treatment-resistant 
        cancers, where conventional methods often fall short. Studies have shown that integrating 
        broad-panel NGS into cancer care can impact clinical decision-making in up to 30% of cases, 
        leading to more personalized and effective treatment strategies.
      </p>
      <p className="text-gray-600 leading-relaxed text-base text-justify">
        By combining cutting-edge sequencing, advanced bioinformatics, and curated clinical evidence, 
        Operify Health empowers oncologists to move from uncertainty to precision—ensuring every cancer 
        patient's care is as individualized as their diagnosis.
      </p>
    </section>
  );
}